FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

323110001: Co-beneldopa 12.5mg/50mg dispersible tablet (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    464802011 Co-beneldopa 12.5mg/50mg dispersible tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    717324015 Co-beneldopa 12.5mg/50mg dispersible tablet (substance) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
    1190004016 Co-beneldopa 12.5mg/50mg dispersible tablet (product) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    46679501000001116 Co-beneldopa 12.5mg/50mg dispersible tablets sugar free en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Co-beneldopa 12.5mg/50mg dispersible tablet Is a Co-beneldopa product false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has active ingredient Central nervous system agent false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Is a Product containing benserazide and levodopa false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has active ingredient Benserazide false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspension.oral ontology form and route false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has active ingredient Benserazide hydrochloride false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has manufactured dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has specific active ingredient Benserazide hydrochloride false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has specific active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Is a Co-beneldopa false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has basis of strength substance Benserazide false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-beneldopa 12.5mg/50mg dispersible tablet - product Is a False Co-beneldopa 12.5mg/50mg dispersible tablet Inferred relationship Existential restriction modifier
    Madopar 62.5 dispersible tablets (Roche Products Ltd) Is a False Co-beneldopa 12.5mg/50mg dispersible tablet Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablets 100 tablet Is pack of False Co-beneldopa 12.5mg/50mg dispersible tablet Inferred relationship Existential restriction modifier
    Co-beneldopa 12.5mg/50mg dispersible tablets 100 tablet Has VMP False Co-beneldopa 12.5mg/50mg dispersible tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start